A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Public ClinicalTrials.gov record NCT03896581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Study identification
- NCT ID
- NCT03896581
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Bimekizumab Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2019
- Primary completion
- Dec 7, 2021
- Completion
- Feb 13, 2022
- Last update posted
- Jan 27, 2026
2019 – 2022
United States locations
- U.S. sites
- 33
- U.S. states
- 22
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pa0011 50017 | Phoenix | Arizona | 85037 | — |
| Pa0011 50035 | San Diego | California | 92128 | — |
| Pa0011 50004 | Tustin | California | 92780 | — |
| Pa0011 50033 | Palm Harbor | Florida | 34684 | — |
| Pa0011 50037 | Tampa | Florida | 33613 | — |
| Pa0011 50039 | Atlanta | Georgia | 30342 | — |
| Pa0011 50024 | Boise | Idaho | 83702 | — |
| Pa0011 50028 | Lexington | Kentucky | 40504 | — |
| Pa0011 50023 | Baton Rouge | Louisiana | 70836 | — |
| Pa0011 50015 | Hagerstown | Maryland | 21740 | — |
| Pa0011 50026 | Wheaton | Maryland | 20902 | — |
| Pa0011 50047 | Boston | Massachusetts | 02115-5817 | — |
| Pa0011 50019 | Lansing | Michigan | 48911 | — |
| Pa0011 50016 | St Louis | Missouri | 63141 | — |
| Pa0011 50005 | Freehold | New Jersey | 07728 | — |
| Pa0011 50029 | Albuquerque | New Mexico | 87102 | — |
| Pa0011 50010 | Brooklyn | New York | 11201 | — |
| Pa0011 50011 | New York | New York | 10003 | — |
| Pa0011 50034 | Rochester | New York | 14642 | — |
| Pa0011 50125 | Charlotte | North Carolina | 28210 | — |
| Pa0011 50031 | Salisbury | North Carolina | 28144 | — |
| Pa0011 50040 | Vandalia | Ohio | 45377 | — |
| Pa0011 50020 | Duncansville | Pennsylvania | 16635 | — |
| Pa0011 50064 | Philadelphia | Pennsylvania | 19104 | — |
| Pa0011 50006 | Wyomissing | Pennsylvania | 19610 | — |
| Pa0011 50008 | Johnston | Rhode Island | 02919 | — |
| Pa0011 50021 | Summerville | South Carolina | 29486 | — |
| Pa0011 50001 | Jackson | Tennessee | 38305 | — |
| Pa0011 50012 | Memphis | Tennessee | 38119-5214 | — |
| Pa0011 50002 | Austin | Texas | 78731 | — |
| Pa0011 50036 | Mesquite | Texas | 75150 | — |
| Pa0011 50009 | Waco | Texas | 76710 | — |
| Pa0011 50050 | Beckley | West Virginia | 25801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03896581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03896581 live on ClinicalTrials.gov.